UK

A new drug has been found to slow the progression of Alzheimer’s, with experts hailing it as a “turning point” in the fight against the disease. Donanemab was found to slow “clinical decline” by up to 35%, allowing people with Alzheimer’s to continue performing day-to-day tasks such as shopping, housekeeping, managing their finances and taking
0 Comments